Show simple item record

dc.contributor.authorLuqmani, R
dc.contributor.authorLee, E
dc.contributor.authorSingh, S
dc.contributor.authorGillett, M
dc.contributor.authorSchmidt, WA
dc.contributor.authorBradburn, M
dc.contributor.authorDasgupta, B
dc.contributor.authorDiamantopoulos, AP
dc.contributor.authorForrester-Barker, W
dc.contributor.authorHamilton, W
dc.contributor.authorMasters, S
dc.contributor.authorMcDonald, B
dc.contributor.authorMcNally, E
dc.contributor.authorPease, C
dc.contributor.authorPiper, J
dc.contributor.authorSalmon, J
dc.contributor.authorWailoo, A
dc.contributor.authorWolfe, K
dc.contributor.authorHutchings, A
dc.date.accessioned2017-02-13T15:26:56Z
dc.date.issued2016-11
dc.description.abstractBackground: Giant cell arteritis (GCA) is a relatively common form of primary systemic vasculitis, which, if left untreated, can lead to permanent sight loss. We compared ultrasound as an alternative diagnostic test with temporal artery biopsy, which may be negative in 9–61% of true cases. Objective: To compare the clinical effectiveness and cost-effectiveness of ultrasound with biopsy in diagnosing patients with suspected GCA. Design: Prospective multicentre cohort study. Setting: Secondary care. Participants: A total of 381 patients referred with newly suspected GCA. Main outcome measures: Sensitivity, specificity and cost-effectiveness of ultrasound compared with biopsy or ultrasound combined with biopsy for diagnosing GCA and interobserver reliability in interpreting scan or biopsy findings. Results: We developed and implemented an ultrasound training programme for diagnosing suspected GCA. We recruited 430 patients with suspected GCA. We analysed 381 patients who underwent both ultrasound and biopsy within 10 days of starting treatment for suspected GCA and who attended a follow-up assessment (median age 71.1 years; 72% female). The sensitivity of biopsy was 39% [95% confidence interval (CI) 33% to 46%], which was significantly lower than previously reported and inferior to ultrasound (54%, 95% CI 48% to 60%); the specificity of biopsy (100%, 95% CI 97% to 100%) was superior to ultrasound (81%, 95% CI 73% to 88%). If we scanned all suspected patients and performed biopsies only on negative cases, sensitivity increased to 65% and specificity was maintained at 81%, reducing the need for biopsies by 43%. Strategies combining clinical judgement (clinician’s assessment at 2 weeks) with the tests showed sensitivity and specificity of 91% and 81%, respectively, for biopsy and 93% and 77%, respectively, for ultrasound; cost-effectiveness (incremental net monetary benefit) was £485 per patient in favour of ultrasound with both cost savings and a small health gain. Inter-rater analysis revealed moderate agreement among sonographers (intraclass correlation coefficient 0.61, 95% CI 0.48 to 0.75), similar to pathologists (0.62, 95% CI 0.49 to 0.76). Limitations: There is no independent gold standard diagnosis for GCA. The reference diagnosis used to determine accuracy was based on classification criteria for GCA that include clinical features at presentation and biopsy results. Conclusion: We have demonstrated the feasibility of providing training in ultrasound for the diagnosis of GCA. Our results indicate better sensitivity but poorer specificity of ultrasound compared with biopsy and suggest some scope for reducing the role of biopsy. The moderate interobserver agreement for both ultrasound and biopsy indicates scope for improving assessment and reporting of test results and challenges the assumption that a positive biopsy always represents GCA. Future work: Further research should address the issue of an independent reference diagnosis, standards for interpreting and reporting test results and the evaluation of ultrasound training, and should also explore the acceptability of these new diagnostic strategies in GCA.en_GB
dc.description.sponsorshipThe research reported in this issue of the journal was funded by the HTA programme as project number 08/64/01.en_GB
dc.identifier.citationVol. 20, Issue 90, 2016en_GB
dc.identifier.doi10.3310/hta20900
dc.identifier.urihttp://hdl.handle.net/10871/25805
dc.language.isoenen_GB
dc.publisherNIHR Health Technology Assessment Programmeen_GB
dc.rights© Queen’s Printer and Controller of HMSO 2016. This work was produced by Luqmani et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UKen_GB
dc.titleThe role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness studyen_GB
dc.typeReporten_GB
dc.date.available2017-02-13T15:26:56Z
dc.identifier.issn1366-5278
dc.identifier.journalHealth Technology Assessmenten_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record